FindTrial
Sign In

Neuromuscular Electrostimulation and Phototherapy in the prevention and treatment of Muscular Loss

Association of Neuromuscular Electrostimulation and Photobiomodulation in the prevention and treatment of Sarcopenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-68m8zh2
Enrollment
Unknown
Registered
2024-09-27
Start date
2024-08-30
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

This is a two-arm, double-blind, randomized controlled clinical study. Experimental group: 14 elderly women will receive, three times a week over 4 weeks, neuromuscular electrical stimulation at the h
E02.774
E02.331

Sponsors

Universidade Federal de Mato Grosso do Sul
Lead Sponsor
Universidade Federal de Mato Grosso do Sul
Collaborator

Eligibility

Sex/Gender
Female
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: Elderly females; over 60 years old; with normal cognition

Exclusion criteria

Exclusion criteria: Male subject; aged under 60 years; with musculoskeletal injuries; cognitive impairment; chronic diseases such as uncontrolled hypertension, diabetes, neoplasms and kidney diseases

Design outcomes

Primary

MeasureTime frame
To evaluate the progression of muscle mass loss in different therapeutic strategies using ultrasound of the muscles of the lower limbs—

Secondary

MeasureTime frame
It is expected that the strength of the quadriceps femoris and gastrocnemius muscles will improve and the muscle volume will increase, optimizing gait, balance, flexibility and quality of life, measured using functional tests and quality of life questionnaires.—

Countries

Brazil

Contacts

Public ContactAdalberto Corazza

Universidade Federal de Mato Grosso do Sul

adalberto.corazza@ufms.br+55 (67) 99991-4832

Outcome results

None listed

Source: REBEC (via WHO ICTRP)